M&T Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.1M | Sell |
|
|||||
|
2025
Q2 | $2.67M | Buy |
|
|||||
|
2025
Q1 | $2.12M | Sell |
|
|||||
|
2024
Q4 | $2.03M | Sell |
|
|||||
|
2024
Q3 | $2.38M | Buy |
|
|||||
|
2024
Q2 | $2.05M | Buy |
|
|||||
|
2024
Q1 | $960K | Sell |
|
|||||
|
2023
Q4 | $1.3M | Sell |
|
|||||
|
2023
Q3 | $1.24M | Buy |
|
|||||
|
2023
Q2 | $1.3M | Sell |
|
|||||
|
2023
Q1 | $1.38M | Buy |
|
|||||
|
2022
Q4 | $1.48M | Sell |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $662K | Sell |
|
|||||
|
2022
Q1 | $763K | Buy |
|
|||||
|
2021
Q4 | $608K | Buy |
|
|||||
|
2021
Q3 | $674K | Buy |
|
|||||
|
2021
Q2 | $604K | Sell |
|
|||||
|
2021
Q1 | $519K | Sell |
|
|||||
|
2020
Q4 | $495K | Sell |
|
|||||
|
2020
Q3 | $569K | Sell |
|
|||||
|
2020
Q2 | $626K | Buy |
|
|||||
|
2020
Q1 | $402K | Sell |
|
|||||
|
2019
Q4 | $475K | Sell |
|
|||||
|
2019
Q3 | $388K | Buy |
|
|||||
|
2019
Q2 | $339K | Sell |
|
|||||
|
2019
Q1 | $495K | Sell |
|
|||||
|
2018
Q4 | $387K | Buy |
|
|||||
|
2018
Q3 | $448K | Buy |
|
|||||
|
2018
Q2 | $466K | Buy |
|
|||||
|
2018
Q1 | $502K | Buy |
|
|||||
|
2017
Q4 | $522K | Buy |
|
|||||
|
2017
Q3 | $477K | Sell |
|
|||||
|
2017
Q2 | $331K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $326K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $307K | Sell |
|
|||||
|
2015
Q4 | $761K | Buy |
|
|||||
|
2015
Q3 | $475K | Sell |
|
|||||
|
2015
Q2 | $1.14M | Sell |
|
|||||
|
2015
Q1 | $1.03M | Sell |
|
|||||
|
2014
Q4 | $962K | Sell |
|
|||||
|
2014
Q3 | $945K | Buy |
|